NASDAQ:CPIX Cumberland Pharmaceuticals (CPIX) Stock Price, News & Analysis → **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (From Huge Alerts) (Ad) Free CPIX Stock Alerts $1.58 +0.01 (+0.64%) (As of 05/23/2024 ET) Add Compare Share Share Today's Range$1.56▼$1.5850-Day Range$1.42▼$1.8852-Week Range$1.42▼$2.36Volume477 shsAverage Volume10,780 shsMarket Capitalization$22.42 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Cumberland Pharmaceuticals alerts: Email Address Ad Behind the MarketsA personal note from Behind The Markets' CEO Dylan Jovine...Today, I'm offering you the chance to receive a PLATINUM BTM subscription for up to 90% OFF! If you want to see just how much your mystery discount is...You can UNCOVER YOUR MYSTERY DISCOUNT HERE! About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.Read More CPIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CPIX Stock News HeadlinesMay 23 at 8:47 PM | msn.comMan arrested after victim texts 'help' to Cumberland County policeMay 23 at 3:46 PM | yahoo.comCumberland man jailed on felony assault chargeMay 22 at 11:04 AM | msn.comWilderness hike to Devil's Breakfast Table on Cumberland Trail is May 25May 22 at 11:04 AM | msn.comFormer Cumberland County basketball coach wins civil lawsuit accusing him of sexual abuseMay 21 at 11:56 PM | msn.comMetro government to recommend safety changes along Cumberland River months after Riley Strain’s deathMay 21 at 6:56 PM | msn.comCumberland House, Sask., has limited access to food, supplies, while Highway 123 is a 'muddy road,' locals sayMay 21 at 1:55 PM | msn.comCumberland Democrats out of step with budget priorities because of Republican controlMay 21 at 8:55 AM | nj.comGirls Golf: Cumberland sweeps Salem/Cumberland County TournamentMay 20, 2024 | msn.comCumberland County woman charged with aggravated assault with a deadly weaponMay 18, 2024 | americanbankingnews.comCumberland Pharmaceuticals (NASDAQ:CPIX) Earns Hold Rating from Analysts at StockNews.comMay 17, 2024 | americanbankingnews.comShort Interest in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Grows By 5.8%May 13, 2024 | msn.comCumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2024 Earnings Call TranscriptMay 11, 2024 | nj.comWatts, Wallace lead Millville sweep at Cumberland County Track & Field ChampionshipsMay 11, 2024 | nj.comCoastal flood advisory for Cumberland County until early Sunday morningMay 11, 2024 | msn.comCumberland County slated to direct $500k in opioid relief funds toward youth and family programsMay 10, 2024 | msn.comVolunteers sworn into Cumberland County CASA programMay 10, 2024 | yahoo.comCumberland County residents inducted to Pennsylvania Voter Hall of FameMay 9, 2024 | msn.comChemical spill forces evacuation of Cumberland County ChipotleMay 9, 2024 | nj.comCoastal flood watch issued for Cumberland County for Friday and SaturdayMay 9, 2024 | nj.comCoastal flood advisory affecting Cumberland County until 2 a.m. FridayMay 9, 2024 | msn.comEF2 tornado causes destruction, power outages in New CumberlandMay 8, 2024 | msn.comCumberland County Schools to invest $3M to install weapons detectors for upcoming school yearMay 8, 2024 | finanznachrichten.deCumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company UpdateMay 8, 2024 | msn.comCumberland Valley School Board director resigns in wake of decision to allow anti-bullying activist to speak at assemblyMay 8, 2024 | msn.comCumberland Co. schools to add weapon detection systems to all schoolsSee More Headlines Receive CPIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/05/2024Today5/24/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CPIX CUSIP23077010 CIK1087294 Webwww.cumberlandpharma.com Phone(615) 255-0068Fax615-255-0094Employees91Year Founded1999Profitability EPS (Most Recent Fiscal Year)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,280,000.00 Net Margins-21.67% Pretax Margin-21.52% Return on Equity0.21% Return on Assets0.08% Debt Debt-to-Equity Ratio0.59 Current Ratio1.37 Quick Ratio1.21 Sales & Book Value Annual Sales$39.55 million Price / Sales0.57 Cash Flow$0.66 per share Price / Cash Flow2.39 Book Value$1.92 per share Price / Book0.82Miscellaneous Outstanding Shares14,190,000Free Float8,046,000Market Cap$22.42 million OptionableOptionable Beta0.17 Social Links 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. A. J. Kazimi MBA (Age 66)Founder, Chairman, President & CEO Comp: $952.53kMr. John Michael Hamm (Age 68)VP & CFO Comp: $258.38kMr. James Lowrance Herman (Age 69)Executive VP of National Accounts & Chief Compliance Officer Comp: $372.27kMr. Chris T. Bitterman (Age 59)Vice President of Sales & Marketing Comp: $290.87kMr. Todd M. Anthony (Age 63)Vice President of Organizational Development Comp: $304.94kMs. Jean W. Marstiller (Age 74)Senior VP of Administrative Services & Corporate Secretary Comp: $282.17kMr. Adam S. Mostafa (Age 44)Managing Director Ms. Erin Smith GullSenior Corporate Relations AssociateMore ExecutivesKey CompetitorsIterum TherapeuticsNASDAQ:ITRMBullfrog AINASDAQ:BFRGNeuroBo PharmaceuticalsNASDAQ:NRBOBriaCell TherapeuticsNASDAQ:BCTXCytoMed TherapeuticsNASDAQ:GDTCView All Competitors CPIX Stock Analysis - Frequently Asked Questions How have CPIX shares performed in 2024? Cumberland Pharmaceuticals' stock was trading at $1.7917 at the beginning of 2024. Since then, CPIX stock has decreased by 11.8% and is now trading at $1.58. View the best growth stocks for 2024 here. When is Cumberland Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our CPIX earnings forecast. How were Cumberland Pharmaceuticals' earnings last quarter? Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) posted its earnings results on Tuesday, March, 5th. The specialty pharmaceutical company reported ($0.12) EPS for the quarter. The specialty pharmaceutical company had revenue of $9.35 million for the quarter. Cumberland Pharmaceuticals had a positive trailing twelve-month return on equity of 0.21% and a negative net margin of 21.67%. What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO? 9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Cumberland Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS). Who are Cumberland Pharmaceuticals' major shareholders? Cumberland Pharmaceuticals' stock is owned by many different retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include A J Kazimi, A J Kazimi, Caroline Young, James Jones, Joseph C Galante, Kenneth Krogulski, Martin E Cearnal, Martin E Cearnal and William Sumas. View institutional ownership trends. How do I buy shares of Cumberland Pharmaceuticals? Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CPIX) was last updated on 5/24/2024 by MarketBeat.com Staff From Our PartnersBiden replacement revealed?Paradigm PressUrgent Nvidia WarningAltimetryWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsMost important medical advance in 100 yearsThe Oxford ClubNew Options need New Trading StrategiesNetpicksExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.